2 results
Approved WMORecruiting
Primary objective:To improve the PET negativity after two cycles of immuno-chemotherapyPrimary efficacy endpoint:PET 2 assessment according to the five-point scale Deauville criteria (Negative = 1, 2, 3 and Positive = 4, 5), based on central review.…
Approved WMOPending
Primary Objective: To assess the safety of long-term administration of KVD900 in adolescent and adult patients with HAE type I or II.Secondary Objectives: • To assess the long-term efficacy of KVD900 in the treatment of attacks in adolescent and…